COVID-19 vaccine confusion continues to abound.
The AfD has called out the German government for pushing vaccines when it had no scientific evidence that the principal vaccine administered in the country actually saved lives.
The German Ministry of Health under Karl Lauterbach (SPD) admitted to his country’s parliament on September 5th that, with regard to the Pfizer-BioNTech vaccine Comirnaty, no “significant difference in overall mortality” had been found between those vaccinated against COVID-19 and the unvaccinated. The statement came in response to a parliamentary question submitted by AfD MP Roger Beckamp, Junge Freiheit reports.
Beckamp submitted the question based on the study with the identifier C4591001, which was part of the clinical trial information submitted to the German government for Comirnaty’s approval. The study included 43,448 subjects, half of whom received the vaccination while the other half were treated with a placebo.
In comments to Junge Freiheit, Beckamp said that the federal government must now admit what it has known for a long time: the vaccine didn’t work.
Results of the study demonstrate the lack of justification for pushing the Comirnaty COVID-19 vaccine, also known as ‘the Pfizer vaccine’, whether through propaganda, social pressure, or mandates.
In the U.S., an independent analysis of Centers for Disease Control data published in November 2022 found that by April 2022, 4 in 10 deaths from COVID-19 were among those vaccinated or boosted, a data point that remained true at least until August 2022, according to the analysis.
Doctors in Germany are also concerned about waste—heading into the autumn vaccine season—due to how vaccines are packaged.
Exxpress news reports that the German Association of General Practitioners has raised concerns about vaccine waste and overburdening the health care system with logistical headaches due to a simple problem: the packing of the new Pfizer-BioNTech COVID-19 vaccine. The vaccine currently comes only in vials containing six doses. This means either patients will have to be vaccinated in sets of six, which will require additional organisational effort, or a considerable amount of doses will be at risk of being wasted.
“We will once again be faced with an excessive organisational burden if every time a Biontech vaccination is necessary we either have to quickly find five additional people to be vaccinated, postpone the vaccination, or waste five doses of the vaccine,” said Nicola Buhlinger-Göpfarth, vice chair of the association.
Pfizer-BioNTech is working on single-dose packaging, according to Exxpress and other German media.
